Pharmacological Properties of SD-282 – An α-Isoform Selective Inhibitor for p38 MAP Kinase

By  

Pharmacology, Vol. 81, Iss. 3, 2008-01 ,pp. : 204-220

Karger

Access to resources Recommend Favorite

Optimized 4,5-Diarylimidazoles as Potent/Selective Inhibitors of Protein Kinase CK1δ and Their Structural Relation to p38α MAPK

By Halekotte Jakob   Witt Lydia   Ianes Chiara   Krüger Marc   Bührmann Mike   Rauh Daniel   Pichlo Christian   Brunstein Elena   Luxenburger Andreas   Baumann Ulrich   Knippschild Uwe   Bischof Joachim   Peifer Christian  

Molecules, Vol. 22, Iss. 4, 2017-03 ,pp. : 522-522

MDPI

Access to resources Recommend Favorite

Multiple-Dose Up-Titration Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Selexipag, an Orally Available Selective Prostacyclin Receptor Agonist, in Healthy Subjects

By  

Pharmacology, Vol. 94, Iss. 3-4, 2014-09 ,pp. : 148-156

Karger

Access to resources Recommend Favorite

Identification of a Potent Allosteric Inhibitor of Human Protein Kinase CK2 by Bacterial Surface Display Library Screening

By Nienberg Christian   Garmann Claudia   Gratz Andreas   Bollacke Andre   Götz Claudia   Jose Joachim  

Pharmaceuticals, Vol. 10, Iss. 1, 2017-01 ,pp. : 6-6

MDPI

Access to resources Recommend Favorite

Inhibitory Effect of a Potent and Selective Cytosolic Phospholipase A₂α Inhibitor RSC-3388 on Skin Inflammation in Mice

By  

Pharmacology, Vol. 81, Iss. 4, 2008-02 ,pp. : 301-311

Karger

Access to resources Recommend Favorite